10.1002/asia.201700867
Chemistry - An Asian Journal
PER
) δ 6.33 (d, J = 2.8 Hz, 1H), 5.67 (d, J = 8.3 Hz, 1H),
J = 2.4 Hz, 1H), 5.41 (dd, J = 10.8, 3.3 Hz, 1H), 5.17 (dd, J = 10.8, 3.5 Hz,
1H), 5.07–5.00 (m, 1H), 4.47 (t, J = 6.5 Hz, 1H), 4.17–4.04 (m, 3H),
2.17–1.99 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 170.8, 170.6, 170.4,
170.3, 170.1, 170.1, 95.7, 90.4, 70.8, 70.7, 70.4, 68.3, 68.1, 67.2, 67.1,
65.9, 61.7, 61.4, 20.7, 20.6, 20.5, 20.5, 20.5, 20.4.
), 5.18–5.03 (m, 2H), 4.31–4.18 (m, 2H), 3.98–3.92 (m,
0.9 Hz, 1H), 3.51 (dd, J = 12.0, 8.5 Hz, 1H), 2.20–1.96
, J = 6.4 Hz, 3H), 1.15 (d, J = 6.5 Hz, 3H); 13C NMR
) δ 170.9, 170.6, 170.3, 90.9, 71.4, 68.6, 67.9, 64.7,
6.2.
2,3,4,6-Tetra-O-acetyl-D
-mannopyranose (3c).47 (870.7 mg, 90%) [α]2D4
cetyl-2-N-acetyl-
D
-glucosamine (2f).22 (2.04 g, 95%)
+26.71 (c 1.0, CHCl3); IR (cm-1): 3457, 2923, 2853, 1739, 1460, 1371,
213, 1126; 1H NMR (400 MHz, CDCl3) δ 5.39 (dd, J = 9.9, 3.2 Hz, 1H),
5.25 (ddd, J = 9.6, 9.1, 7.0 Hz, 3H), 4.26–4.18 (m, 2H), 4.17–4.07 (m,
2H), 2.15–1.95 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 170.9, 170.3,
170.1, 169.8, 92.0, 70.0, 68.7, 68.3, 66.0, 62.5, 20.9, 20.7, 20.7, 20.7.
0, CHCl3); IR (cm-1): 3291, 2960, 1740, 1662, 1538,
1127; 1H NMR (400 MHz, CDCl3) δ 6.16 (d, J = 3.7 Hz,
8.8 Hz, 0.38H), 5.64 (d, J = 9.0 Hz, 1H), 5.27–5.16 (m,
, 1H), 4.52–4.44 (m, 1H), 4.29–4.20 (m, 2H), 4.14–3.95
H), 2.23–1.90 (m, 23H); 13C NMR (100 MHz, CDCl3) δ
2, 169.0, 168.6, 92.3, 90.5, 72.5, 72.5, 70.5, 69.5, 67.7,
2.6, 50.8, 22.8, 20.8, 20.6, 20.5, 20.4.
2,3,4-Tri-O-acetyl-D
-xylopyranose (3d).46 (461.3 mg, 60%) [α]2D4 +21.89
(c 1.0, CHCl3); IR (cm-1): 2955, 2923, 2854, 1462, 1377, 1260, 1097; 1H
NMR (400 MHz, CDCl3) δ 5.50 (t, J = 9.6, 1H), 5.38 (t, J = 3.3 Hz, 1H),
5.22 (t, J =9.2 Hz, 1H), 4.99–4.91 (m, 1H), 4.83 (dd, J = 9.9, 3.5 Hz, 1H),
4.67 (t, J = 7.7 Hz, 1H), 4.12 (dd, J = 11.7, 5.6 Hz, 1H), 3.88–3.77 (m,
2H), 3.43–3.42 (m, 1H), 2.08(s, 3H), 2.04(s, 3H), 2.03(s, 3H); 13C NMR
(100 MHz, CDCl3) δ 170.9, 170.2, 170.1, 170.1, 169.9, 95.9, 95.8, 90.3,
90.1, 71.2, 69.2, 69.1, 69.0, 62.7, 58.4, 58.2, 20.9, 20.8, 20.7, 20.7, 20.5.
O-acetate (2g).43 (3.39 g, 90%) [α]2D4 +29.72 (c 1.0,
2953, 1740, 1431, 1367, 1209; 1H NMR (400 MHz,
J = 3.7 Hz, 1H), 5.66 (d, J = 8.3 Hz, 0.71H), 5.50–5.40
J = 3.7, 2.6 Hz, 2H), 5.23 (t, J = 9.1 Hz, 1H), 5.15–4.91
0 (m, 3H), 4.20–3.95 (m, 6H), 3.91–3.71 (m, 4H), 2.19–
C NMR (100 MHz, CDCl3) δ 171.5, 170.6, 170.2, 169.0,
, 72.5, 72.5, 70.5, 69.5, 67.7, 67.4, 61.5, 61.4, 52.6,
0.7, 20.5, 20.4.
2,3,4-Tri-O-acetyl-L
-fucopyranose (3e).48 (525.3 mg, 65%) [α]2D4 +21.89
(c 1.0, CHCl3); IR (cm-1): 2955, 2923, 2854, 1462, 1377, 1260, 1097; 1H
NMR (400 MHz, CDCl3) δ 5.45 (t, J = 2.9, 1H), 5.39 (dd, J = 10.4, 2.8 Hz,
1H), 5.29 (d, J =3.8 Hz, 1H), 5.13 (dd, J = 10.8, 3.5, 1H), 4.68–4.61 (m,
1H), 4.40 (q, J = 6.4 Hz, 1H), 4.24 (t, J = 5.0 Hz, 1H), 3.84 (d, J = 7.8 Hz,
1H), 3.58 (d, J = 3.1 Hz, 1H), 3.45 (s, 1H), 2.18–1.96 (m, 17H), 1.21 (d, J
= 6.4 Hz, 1H), 1.13 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
170.4, 170.1, 169.9, 169.8, 169.3, 169.0, 92.0, 89.0, 89.7, 70.5, 70.3,
70.2, 70.0, 67.8, 67.7, 67.2, , 67.1, 20.9, 20.8, 20.7, 20.6, 20.5, 20.4,
15.8, 15.7
6-tetra-O-acetyl-α-D
-glucopyranoside (2h).18 (1.93 g,
93 (c 1.0, CHCl3); IR (cm-1): 2939, 1739, 1460, 1372,
MR (400 MHz, CDCl3) δ 5.43 (t, J = 9.8 Hz, 1H), 5.03 (t,
.94–4.82 (m, 2H), 4.23 (dd, J = 12.3, 4.6 Hz, 1H), 4.07
Hz, 1H), 3.95 (ddd, J = 10.2, 4.5, 2.3 Hz, 1H), 3.38 (s,
m, 12H); 13C NMR (100 MHz, CDCl3) δ 170.5, 170.0,
, 70.6, 69.9, 68.3, 67.0, 61.8, 55.3, 20.6, 20.5, 20.5.
mido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-α-
D
-glycero-
D
2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-
D
-glucopyranose
(3f).46
opyranosonate (2i).44 (2.48 g, 91%) [α]2D4 -1.89 (c 1.0,
: 3253, 3071, 2924, 1734, 1720, 1649, 1570, 1434,
, 1211, 1159, 1130; 1H NMR (400 MHz, CDCl3) δ 5.85
H), 5.35 (dd, J = 5.2, 1.8 Hz, 1H), 5.26–5.16 (m, 2H),
(dd, J = 12.3, 2.3 Hz, 1H), 4.23–4.10 (m, 2H), 4.01 (dd,
H), 3.85 (s, 3H), 2.13 (s, 3H), 2.09 (s, 3H), 2.02 (s, 3H),
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.5, 171.1,
2, 169.0, 94.8, 72.0, 71.2, 69.2, 68.3, 62.5, 53.2, 48.9,
0.8, 20.7, 20.7.
(684.2 mg, 71%) [α]2D4 +41.48 (c 1.0, CHCl3); IR (cm-1): 3366, 2960., 2360,
1744, 1661, 1542, 1371, 1244; 1H NMR (400 MHz, CDCl3) δ 6.00 (d, J =
9.3 Hz, 1H), 5.31–5.27 (m, 1H), 5.26–5.23 (m, 1H), 5.12 (t, J = 9.4 Hz,
1H), 4.23–4.09 (m, 4H), 2.10–1.94 (mm, 12H); 13C NMR (100 MHz, CDCl3)
δ 171.4, 171.1, 170.9, 169.5, 91.3, 70.9, 68.2, 67.2, 62.0, 52.2, 23.0,
20.7, 20.7, 20.6.
4’-O-(2,3,4,6-Tetra-O-acetyl-β-
D-galactopyranosyl)-2’,3’,6’-tri-O-
acetyl-
D
-glucopyranose (3g).47 (1.3 g, 75%) [α]D24 +33.99 (c 1.0, CHCl3);
IR (cm-1): 3433, 2923, 2853, 1740, 1432, 1367, 1214, 1171; 1H NMR
(400 MHz, CDCl3) δ 5.50 (t, J = 9.6 Hz, 1H), 5.33 (d, J = 3.5 Hz, 2H),
5.21 (t, J = 9.3 Hz, 1H), 5.14–5.04 (m, 1H), 4.98–4.90 (m, 1H), 4.84–4.75
(m, 1H), 4.73 (d, J = 6.3 Hz, 1H), 4.52–4.43 (m, 3H), 4.20–4.01 (m, 6H),
3.87 (t, J = 6.9 Hz, 2H), 3.76 (dd, J = 20.0, 10.4 Hz, 2H), 3.69–3.60 (m,
1H), 2.15–1.93 (m, 26H); 13C NMR (100 MHz, CDCl3) δ 171.1, 170.7,
170.6, 170.5, 170.1, 170.1, 100.4, 95.6, 90.5, 71.2, 71.1, 70.8, 70.2, 69.4,
68.4, 67.7, 64.3, 20.8, 20.6, 20.6, 20.6, 20.5, 16.0, 15.9.
,3-O-isopropylidene-D
-ribofuranose (2j).45 (1.11 g,
(c 1.0, CHCl3); IR (cm-1): 2990, 1739, 1436, 1373, 1209,
MR (400 MHz, CDCl3) δ 6.21 (s, 1H), 4.71 (s, 1H), 4.46
), 4.11 (dd, J = 6.7, 3.4 Hz, 2H), 2.08 (s, 3H), 2.05 (s,
, 1.33 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.7,
3, 85.5, 85.3, 81.7, 64.3, 26.6, 25.2, 21.4, 21.0.
cetyl-D
-glucopyranose (3a).46 (842.9 mg, 87%) [α]2D4
HCl3); IR (cm-1): 3468, 2922, 2853, 1740, 1456, 1367,
MR (400 MHz, CDCl3) δ 5.53 (t, J = 9.6 Hz, 1H), 5.46 (d,
25 (t, J = 9.6 Hz, 1H), 5.08 (t, J = 9.0 Hz, 1H), 4.90 (dd,
1H), 4.29–4.20 (m, 2H), 4.17–4.09 (m, 2H), 2.10–1.99
MR (100 MHz, CDCl3) δ 170.9, 170.8, 170.6, 170.2,
4, 90.0, 73.1, 72.3, 71.9, 71.1, 69.9, 69.6, 68.5, 68.4,
0.7, 20.6, 20.6, 20.5, 20.5.
5-O-Acetyl-2,3-O-isopropylidene-D
-ribofuranose (3j).49 (341.3 mg,
53%) [α]2D4 -17.39 (c 1.0, CHCl3); IR (cm-1): 3446, 2989, 2943, 1744, 1375,
1241, 1161; 1H NMR (400 MHz, CDCl3) δ 5.46 (s, 1H), 4.70 (d, J = 5.9
Hz, 1H), 4.65–4.62 (m, 2H), 4.40–4.35 (m, 1H), 4.34–4.28 (m, 2H), 4.16–
4.08 (m, 3H), 2.10 (s, 3H), 1.48 (s, 3H), 1.33 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 171.0, 112.4, 102.8, 85.6, 84.3, 81.8, 68.1, 65.2, 26.3, 24.7,
20.7.
cetyl-
D
-glactopyranose (3b).47 (755.2 mg, 78%) [α]2D4
4’-O-(2,3,4,6-Tetra-O-acetyl-α-D-gulcopyranosyl)-2’,3’,6’-tri-O-acetyl-
HCl3); IR (cm-1): 3467, 2925, 1738, 1433, 1369, 1212,
D-glucopyranose (3l).18 (1.53 g, 966%) [α]D24 +82.66 (c 1.0, CHCl3); IR
MR (400 MHz, CDCl3) δ 5.53 (t, J = 3.4 Hz, 1H), 5.48 (d,
(cm-1): 3503, 2923, 2853, 1739, 1429, 1366, 1224, 1148, 1127; 1H NMR
use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.